Both in Pharmaceuticals
Rocket Pharmaceuticals vs Upstream Bio
Over the past year RCKT returned −21.0% and UPB returned −70.1%; their daily moves had a correlation of 0.26.
RCKT −21.0% UPB −70.1%Growth of $1, one year, split-adjusted
| Metric | RCKT | UPB |
|---|---|---|
| Price | $2.59 | $5.19 |
| Market cap | $284.3M | $284.3M |
| Today | −0.77% | −2.08% |
| 1 month | −32.9% | −22.4% |
| 6 months | −24.8% | −40.9% |
| Year to date | −26.2% | −80.9% |
| 1 year | −20.6% | −69.9% |
| Revenue growth (YoY) | — | −17.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −5136.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 90.0× |
| Net cash | $262.5M | $261.3M |
| Dividend yield | — | — |
| Volatility (60d) | 61.1% | 55.6% |
| Short % of float | 17.6% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).